Equities

Beijing Luzhu Biotechnology Co Ltd

Beijing Luzhu Biotechnology Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)21.55
  • Today's Change-0.05 / -0.23%
  • Shares traded2.20k
  • 1 Year change-34.70%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 03:14 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in CNYView more

In 2023, Beijing Luzhu Biotechnology Co Ltd increased its cash reserves by 273.89%, or 188.92m. Cash Flow from Financing totalled 273.17m or -- of revenues. In addition the company used 189.95m for operations while cash from investing totalled 98.58m.
Cash flow per share-1.38
Price/Cash flow per share--
Book value per share5.05
Tangible book value per share5.03
More ▼

Balance sheet in CNYView more

Beijing Luzhu Biotechnology Co Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio5.97
Quick ratio5.91
Total debt/total equity0.0305
Total debt/total capital0.0296
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.